Validose

Validose is a health technology company focused on improving medication adherence in clinical trials, a critical factor that contributes to the failure of an estimated 30% of such studies. The company was established as a portfolio company of the MedTech venture studio 10XBeta and has its headquarters in Brooklyn, New York. In early 2025, Validose secured $2 million in a pre-seed funding round led by Peter Bauer's Family Office, 10XBeta, and Interstate Fusion Ventures.

The core of Validose's offering is a comprehensive hardware and software ecosystem designed to address the persistent challenge of patient non-adherence in drug development. The platform provides objective, real-time data on when and how patients take their medication, moving beyond unreliable self-reporting methods like written journals or basic tracking apps. This is achieved through its proprietary Dose Exoskeleton, a multi-sensor, adaptable attachment that records adherence metrics for various medication forms, including ophthalmic drops, nasal sprays, and pill delivery systems, without altering the original drug packaging.

The system offers a two-sided interface. For trial participants, a Patient Portal delivers personalized dose reminders, secure messaging, and AI-driven behavioral coaching to encourage compliance. For trial coordinators, a Clinician Dashboard provides immediate access to real-time adherence data, enabling timely interventions and more informed decision-making. By linking precise remote data capture with behavioral modeling, Validose aims to reduce trial costs, shorten development timelines, and ultimately improve the reliability of clinical trial outcomes. The company plans to launch its first product, a smart-dose eye-dropper, in the second quarter of 2025.

Keywords: medication adherence, clinical trials, smart-dose technology, digital health, patient engagement, real-time data, pharmaceutical development, drug delivery, health technology, precision dosing, remote patient monitoring, behavioral coaching, dose tracking, ophthalmic solutions, intranasal drug delivery, MedTech, clinical trial optimization, patient compliance, data-driven healthcare, biometrically secure device